Trial intelligence / Profile preview

ECHACISS: Deferiprone and Cochlear Implantation for Superficial Siderosis

jRCTs031180438Recruiting

Start
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of deferiprone in superficial siderosis (SS) (2 arms). Primary endpoints: Hearing ability, Ataxia and 1 more. Started Apr 2019; status: recruiting.

02

Drugs

deferiprone
03

Conditions

superficial siderosis (SS)

Beyond the preview

Go deeper on jRCTs031180438.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031180438.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call